DiaGen Ai Inc. Announces Letter of Intent to Merge With Issuer Linceis Capital Corp
VANCOUVER, BC, CANADA, May 8, 2024 /EINPresswire.com/ -- DiaGen AI Inc. (“DiaGen” or the “Company”) founded in 2021 to advance its proprietary generative artificial intelligence engine in protein design, drug discovery and diagnostics for health, …